Patents Assigned to PATHOMIQ INC.
  • Patent number: 12500000
    Abstract: Disclosed are systems and methods for predicting patient response to a treatment option. In one embodiment, the image slides from patient tissue samples are divided into patches and morphological patterns correlated with a disease outcome are labeled and given a patch-level score, based on whether the morphological patterns occur only in patients with good outcomes or patients with poor outcomes. A patient-level score can be generated based, at least partly, on the patch-level scores. Patch-level scores can identify regions of interest for targeted biomarker identification.
    Type: Grant
    Filed: April 29, 2024
    Date of Patent: December 16, 2025
    Assignee: PATHOMIQ INC.
    Inventors: Parag Jain, Rajat Roy, Bijay Shankar Jaiswal
  • Patent number: 12094571
    Abstract: Methods and systems for identifying and quantifying molecular biomarkers and for predicting patient response to cancer therapy are provided. The disclosed methods and systems make use of artificial intelligence to capture morphometric changes from histopathology tissue that correlate with molecular changes. The system may analyze molecular markers which are predictive of tumor response and have no defined correlation with morphological features. The system may use artificial intelligence to correlate morphometric changes with critical gene modifications and molecular changes.
    Type: Grant
    Filed: February 11, 2021
    Date of Patent: September 17, 2024
    Assignee: PATHOMIQ INC.
    Inventors: Parag Jain, Rajat Roy, Bijay Shankar Jaiswal
  • Patent number: 11972870
    Abstract: Disclosed are systems and methods for predicting patient response to a treatment option. In one embodiment, the image slides from patient tissue samples are divided into patches and morphological patterns correlated with a disease outcome are labeled and given a patch-level score, based on whether the morphological patterns occur only in patients with good outcomes or patients with poor outcomes. A patient-level score can be generated based, at least partly, on the patch-level scores. Patch-level scores can identify regions of interest for targeted biomarker identification.
    Type: Grant
    Filed: October 24, 2022
    Date of Patent: April 30, 2024
    Assignee: PATHOMIQ INC.
    Inventors: Parag Jain, Rajat Roy, Bijay Shankar Jaiswal
  • Patent number: 11482335
    Abstract: Disclosed are systems and methods for predicting patient response to a treatment option. In one embodiment, the image slides from patient tissue samples are divided into patches and morphological patterns correlated with a disease outcome are labeled and given a patch-level score, based on whether the morphological patterns occur only in patients with good outcomes or patients with poor outcomes. A patient-level score can be generated based, at least partly, on the patch-level scores. Patch-level scores can identify regions of interest for targeted biomarker identification.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: October 25, 2022
    Assignee: PATHOMIQ INC.
    Inventors: Parag Jain, Rajat Roy, Bijay Shankar Jaiswal